UBU3:XETRA:XETRA-UBS Irl plc - MSCI USA UCITS USD A-dis (EUR)

ETF | Others |

Last Closing

USD 121.845

Change

-0.01 (0.00)%

Market Cap

USD 0.82B

Volume

83.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.80 (+1.61%)

USD 502.95B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.26 (+1.62%)

USD 191.96B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.42 (+1.54%)

USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.39 (+1.50%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.52 (+2.21%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+2.84 (+2.08%)

USD 102.11B
JARI:XETRA Amundi Index Solutions - Amund..

+0.62 (+1.35%)

USD 102.11B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.78 (+1.59%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+10.98 (+2.10%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.39 (+1.75%)

USD 79.79B

ETFs Containing UBU3:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.57% 86% B+ 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.57% 85% B 83% B
Trailing 12 Months  
Capital Gain 21.99% 83% B 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.99% 83% B 81% B-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 14.41% 86% B+ 83% B
Dividend Return 14.41% 86% B+ 81% B-
Total Return N/A 38% F 96% N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.96% 37% F 48% F
Risk Adjusted Return 96.28% 95% A 95% A
Market Capitalization 0.82B 74% C 65% D

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.